aap Implantate AG (ETR:AAQ1)
Germany flag Germany · Delayed Price · Currency is EUR
1.630
+0.080 (5.16%)
Aug 5, 2026, 5:35 PM CET

aap Implantate AG Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
12.2812.0711.512.1512.72
Revenue Growth
1.69%5.01%-5.39%-4.46%42.11%
Cost of Revenue
1.181.41.521.581.82
Gross Profit
11.110.679.9810.5810.9
Selling, General & Admin
65.996.976.886.72
Depreciation & Amortization Expenses
1.871.863.981.671.84
Other Operating Expenses
6.987.217.716.596.59
Total Operating Expenses
14.8415.0618.6615.1415.15
Operating Income
-2.51-2.72-7.41-3.39-2.61
Total Non-Operating Income (Expense)
-0.06-0.51-0.11-0.24-0.28
Pretax Income
-2.6-3.23-7.52-3.61-2.86
Provision for Income Taxes
0.01-0.41-0.451.050.34
Net Income
-2.59-3.63-7.96-2.56-2.52
Net Income to Common
-2.59-3.63-7.96-2.56-2.52
Net Income Growth
-----
Shares Outstanding (Basic)
1410865
Shares Outstanding (Diluted)
1410865
Shares Change
34.34%23.90%39.27%21.18%53.27%
EPS (Basic)
-0.19-0.35-0.96-0.39-0.51
EPS (Diluted)
-0.19-0.35-0.96-0.39-0.51
EPS Growth
-----
Free Cash Flow
-1.84-1.36-3.13-2.24-2.8
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-0.13-0.13-0.38-0.38-0.57
Gross Margin
90.39%88.40%86.77%87.03%85.73%
Operating Margin
-20.40%-22.50%-64.48%-27.88%-20.52%
Profit Margin
-21.06%-30.07%-69.26%-21.10%-19.83%
FCF Margin
-14.99%-11.30%-27.25%-18.41%-22.01%
EBITDA
-0.64-0.86-3.34-1.72-0.77
EBITDA Margin
-5.19%-7.08%-29.06%-14.11%-6.02%
EBIT
-2.51-2.72-7.41-3.39-2.61
EBIT Margin
-20.40%-22.50%-64.48%-27.88%-20.52%
Effective Tax Rate
-0.54%12.56%5.96%-29.03%-11.94%